Mortality of People with Parkinson's Disease in a Large UK-Based Cohort Study: Time Trends and Relationship to Disease Duration
Overview
Affiliations
Background: Parkinson's disease (PD) is associated with increased mortality, but little is known about changes over time, and relationship to disease progression.
Objectives: To explore how PD mortality rates have changed over time and their relationship to disease duration and demographics using a large population-based cohort in the UK.
Methods: We included individuals aged 50+ years with a first recording of PD diagnosis and at least two prescriptions of any antiparkinsonian drug actively registered within a general practice from 2006 to 2016 and up to six frequency-matched controls from The Health Improvement Network (THIN) database. We estimated adjusted mortality rates using multivariable Poisson regression.
Results: A total of 10,104 people with a diagnosis of PD and 55,664 people without PD were included. Overall, PD was associated with slightly increased mortality compared to non-PD controls (adjusted mortality rate ratio: 1.14; 95% CI: 1.03 to 1.19). Adjusted mortality rates per 1000 person-years at risk for people with PD approximately doubled in the 5 years following diagnosis from 43 (95% CI: 38 to 48) to 75 (95% CI: 64 to 85). Following adjustments for age, gender, and time since diagnosis, mortality rates between 2007 and 2016 declined more slowly for people with PD (2% per year; 95% CI: 0%-4%) compared to people without PD (5% per year; 95% CI: 3%-6%).
Conclusions: Whilst mortality in PD is only slightly increased overall, it gradually increases with advancing disease. There has been a decline in mortality in PD over time, but this decrease was less pronounced than that in the general population. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.
Cox E, Wade R, Hodgson R, Fulbright H, Phung T, Meader N Health Technol Assess. 2024; 28(30):1-187.
PMID: 39021200 PMC: 11331379. DOI: 10.3310/YDSL3294.
Update: Protective and risk factors for Parkinson disease.
Grotewold N, Albin R Parkinsonism Relat Disord. 2024; 125:107026.
PMID: 38879999 PMC: 11846500. DOI: 10.1016/j.parkreldis.2024.107026.
Trends in parkinson's disease mortality in China from 2004 to 2021: a joinpoint analysis.
Wang S, Jiang S, Wu J, Miao Y, Duan Y, Mu Z BMC Public Health. 2024; 24(1):1091.
PMID: 38641581 PMC: 11031848. DOI: 10.1186/s12889-024-18532-8.
Case-Fatality Rate in Parkinson's Disease: A Nationwide Registry Study.
Sipila J, Kaasinen V, Rautava P, Kyto V Mov Disord Clin Pract. 2024; 11(2):152-158.
PMID: 38386489 PMC: 10883402. DOI: 10.1002/mdc3.13948.
Update: Descriptive epidemiology of Parkinson disease.
Grotewold N, Albin R Parkinsonism Relat Disord. 2024; 120:106000.
PMID: 38233324 PMC: 10922566. DOI: 10.1016/j.parkreldis.2024.106000.